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ttp://dx.doi.org/10.1016/j.ajpath.2014.08.012Obstructive nephropathy, the leading cause of kidney failure in children, can be anatomic or functional.
The underlying causes of functional hydronephrosis are not well understood. miRNAs, which are small
noncoding RNAs, regulate gene expression at the post-transcriptional level. We found that miR-145-5p, a
member of the miR-143/145 cluster that is highly expressed in smooth muscle cells of the renal vascu-
lature, was present in the pelvicalyceal system and the ureter. To evaluate whether the miR-143/145
cluster is involved in urinary tract function we performed morphologic, functional, and gene expression
studies in mice carrying a whole-body deletion of miR-143/145. miR-143/145edeﬁcient mice developed
hydronephrosis, characterized by severe papillary atrophy and dilatation of the pelvicalyceal system
without obvious physical obstruction. Moreover, mutant mice showed abnormal ureteral peristalsis. The
number of ureter contractions was signiﬁcantly higher in miR-143/145edeﬁcient mice. Peristalsis was
replaced by incomplete, short, and more frequent contractions that failed to completely propagate in a
proximal-distal direction. Microarray analysis showed 108 differentially expressed genes in ureters of
miR-143/145edeﬁcient mice. Ninety genes were up-regulated and 18 genes were down-regulated,
including genes with potential regulatory roles in smooth muscle contraction and extracellular matrix-
receptor interaction. We show that miR-143/145 are important for the normal peristalsis of the ureter
and report an association between the expression of these miRNAs and hydronephrosis. (Am J Pathol
2014, 184: 3226e3238; http://dx.doi.org/10.1016/j.ajpath.2014.08.012)Supported by NIH grants HL096735 (R.A.G.) and DK075481 (M.L.S.S.-L.),
and a University of Virginia Children’s Hospital Grant-In-Aid (S.M.).
Disclosures: None declared.Hydronephrosis is a common consequence of obstructive
nephropathy and is one of the most frequent congenital de-
fects diagnosed before birth, affecting 0.9% to 7.7% of
human pregnancies.1 Although most cases of antenatal uri-
nary dilation resolve spontaneously, approximately 20% to
30% of the cases become clinically signiﬁcant after birth.2,3
An interesting feature of urinary tract dilatation is that
approximately half of the cases are not accompanied by
physical obstruction or major structural abnormalities of the
pelvis or ureter. Instead, they are caused by a functional
obstruction, often caused by a failure of the ureteral peri-
staltic mechanism.
miRNAs are a group of small, noncoding, evolutionarily
conserved RNAs that bind to the mRNA of target genes and
negatively regulate their expression. Given that more than 60%
of human protein-coding genes have potential binding sites for
miRNAs and single miRNAs can simultaneously target hun-
dreds of genes,4,5 it is believed thatmiRNAs have a far-reaching
effect on gene expression. miRNAs regulate diverse cellularstigative Pathology.
.processes including stem cell differentiation, apoptosis, prolif-
eration, myogenesis, angiogenesis, hematopoiesis, neuro-
genesis, and epithelial morphogenesis.6e13 Moreover, altered
expression of miRNAs has a causative effect in a wide variety
of human diseases including cancer, as well as renal, cardio-
vascular, neurologic, and age-related pathologies.14
miR-143 and miR-145 are transcribed as a cluster from a
single gene and regulate the fate and plasticity of vascular
smooth muscle cells (SMCs).15 Mice deﬁcient in miR-143/
145 are viable and fertile, but present with low blood pres-
sure as a result of reduced vascular tone.16 These animals
show thinning of the smooth muscle layer of the aorta,
accompanied by a thickening of the extracellular matrix
(ECM). SMCs in the aorta show a reduced number of actin-
stress ﬁbers and a more abundant rough endoplasmic
Table 1 Primer Sequences for RT-qPCR
Gene Forward Reverse
Cacna1d 50-TTCAGAAATGTCTCCACTGTAAAAA-30 50-CATCCCATTCCCTGAAGATG-30
Kcnma1 50-CGTCCACTGGCTTGAGAGTA-30 50-GTACCTGTGGACCGTTTGCT-30
Pla2g4a 50-TTGGTCCCAGTTGCAGAAAT-30 50-GAAGGCACAGAGAAGCCTGA-30
Ppp1r14a 50-GATTTTCCGGCATCTTTCCT-30 50-GGATGCTTGGAGGAGCTGTA-30
Itga4 50-GTTATCCCTCTCCTCCAGGC-30 50-ACAGATGCGGGATCAGAAAG-30
Itgb6 50-AGCTGAAGGATGTTCCCAGA-30 50-TGCAGTCACCCAAGAACAAG-30
Itga3 50-TGAGGGGACACAGGTACACA-30 50-AGACTGAGCGACAACAGCG-30
Thbs2 50-AGTGCACAGCTACAGCCTGA-30 50-ACAGAGTACTGGCGTCGGTC-30
Myocd 50-GAGCCAGTTTCTGGTGGAAA-30 50-GTCCTTCTCTGTTGAAGCCG-30
Acta2 50-TTGCTGACAGGATGCAGAAGGAGA-30 50-ATCTGCTGGAAGGTAGACAGCGAA-30
GAPDH 50-TTGATGGCAACAATCTCCAC-30 50-CGTCCCGTAGACAAAATGGT-30
Figure 1 miR-145-5p is expressed in the smooth muscle layer of the
ureter. A: In situ hybridization for miR-145-5p in ureter sections from WT and
miR-143/145 KO mice. miR-145-5p was expressed in the smooth muscle layer
of the ureter of WT mice (arrow). The speciﬁcity of the staining was
conﬁrmed by the lack of signal in ureters from the miR-143/145 KO mice.
B: In situ hybridization for miR-145-5p at the level of the pelvicalyceal
system in WT mice. miR-145-5p expression was localized to the smooth
muscle layer (arrow). Scale bars: 50 mm (A); 200 mm (B). p, papilla.
miR-143/145 and Hydronephrosisreticulum, which is consistent with a more synthetic pheno-
type. In addition, neointima formation in response to vascular
injury is impeded profoundly in these mice. We previously
reported that miR-145-5p is highly expressed in the juxta-
glomerular (JG) cells and SMCs of renal blood vessels,17 but
its role in the urinary system is not known.
Here, we report that miR-145-5p is expressed in the
pelvicalyceal system and the ureter of normal mice. Based
on these observations, we sought to determine the role of the
miR-143/145 cluster in the urinary system. We found that
miR-143/145edeﬁcient mice develop hydronephrosis after
birth as a result of abnormal ureter peristalsis. Our results
indicate that miR-143/145 are essential for the normal
contractility of the ureter and therefore for normal transport
of urine from the kidney to the bladder.
Materials and Methods
Animals
Mice carrying a whole-body deletion of both miR-143 and
miR-145 were kindly provided by Dr. Eric Olson (Univer-
sity of Texas, Dallas, TX).16 Mice heterozygous for the
deletion were crossed to generate wild-type (WT) and miR-
143/145 knockout (KO) study animals. All animal work was
conducted in accordance with the guidelines approved by
the Council of the American Physiological Society and with
federal laws and regulations. The protocol was reviewed and
approved by the Animal Care and Use Committee of the
University of Virginia. Mice were maintained on a 12-hour
light/dark cycle and given food and water ad libitum.
In Situ Hybridization
Ureters were removed from WT and miR-143/145 KO mice,
immediately ﬁxed in 4% paraformaldehyde at 4C for 24
hours, and embedded in parafﬁn. In situ hybridization was
performed on 5-mmethick sections. Detection of miR-145-
5p was performed as previously described,17 with modiﬁ-
cations. Sections were deparafﬁnized, then ﬁxed in 4%
paraformaldehyde/phosphate-buffered saline, acetylated,
and incubated in hybridization solution consisting of 50%The American Journal of Pathology - ajp.amjpathol.orgformamide, 5 standard saline citrate, 50 mg/mL tRNA, 1%
SDS, and 5 mg/mL heparin at room temperature for 1 hour.
Hybridization was conducted at 37C for 18 hours using 40
nmol/L digoxigenin-labeled locked nucleic acid probe
(Exiqon, Woburn, MA) speciﬁc for mouse miR-145-5p (50-
AGGGATTCCTGGGAAAACTGGAC-30) in hybridization
solution. Sections were washed sequentially once with 5
standard saline citrate at 37C, three times with 0.23227
Medrano et alstandard saline citrate at 40C, and once with 0.2 standard
saline citrate at room temperature. Sites of hybridization
were detected using alkaline phosphataseeconjugated
digoxigenin antibody (Roche Diagnostics Corp., Indian-
apolis, IN) at a 1:4000 dilution, followed by BM Purple AP
substrate color development (Roche). Negative controls
were performed by omitting the probe in the hybridization
step and by using a commercial nontargeting miRNA probe.
Histologic Analysis and Immunostaining
Bouin’s-ﬁxed, parafﬁn-embedded ureter and kidney sections
were stained with hematoxylin and eosin and Masson’s tri-
chrome as described.17 Immunostaining for a-smooth muscle
actin (a-SMA) and renin was performed using mouse
monoclonal antiea-SMA (1:10,000 dilution), rabbit anti-
mouse renin (1:500 dilution), and the appropriate Vectas-
tain ABC kit (Vector Laboratories, Inc., Burlingame, CA) as3228previously described.18 Smooth muscle layer thickness was
quantiﬁed in ureter sections stained with Masson’s trichrome
using ImageJ version 1.47v software (NIH, Bethesda, MD).
Three ureter sections were measured from each animal.
Assessment of Peristaltic Activity
For in vivo analysis of peristaltic activity, WT and miR-143/
145 KO mice between 3 and 10 months of age were anes-
thetized with 250 mg/kg tribromoethanol and placed on a
heating pad at 37C. Ureters were exposed and bathed
continuously in saline prewarmed to 37C. The number of
peristaltic waves in a 3-minute period was recorded by direct
visualization and ﬁlmed.
In vitro peristalsis was assessed in cultured embryo ureter
explants. Ureterswere isolated fromWTandmiR-143/145KO-
embryonic day (E) 16.5 embryos, placed on 6.5-mm poly-
carbonate membrane inserts with a pore size of 0.4 mm (Costar,Figure 2 miR-143/145edeﬁcient mice de-
velop hydronephrosis. A: Kidneys from 2-month-
old WT and miR-143/145 KO mice. miR-143/145
KO mice develop hydronephrosis, which is char-
acterized by marked dilatation of the pelvis and
calyces (arrowheads) and accompanied by severe
atrophy of the papilla (arrow). B: Hematoxylin and
eosin staining of transversal kidney sections of 3-
month-old male mice. miR-143/145 KO kidneys
show severe atrophy of the papilla and dilatation
of the pelvis. Lower panels show in more detail
the boxed areas indicated in the upper panels.
Hematoxylin and eosin staining does not show
morphologic changes at the level of the renal
cortex in mice lacking miR-143/145. The structure
of glomeruli, blood vessels, and tubules is
conserved in mutant mice. Asterisk, glomerulus;
arrows, afferent arteriole. Scale bars: 500 mm (B,
upper panel); 50 mm (B, lower panel). c, cortex;
m, medulla; p, papilla.
ajp.amjpathol.org - The American Journal of Pathology
miR-143/145 and HydronephrosisCambridge, MA), and cultured at the air-medium interface in
DMEM/F12 media supplemented with 5 mg/mL transferrin,
100 mg/mL penicillin, and 100U/mL streptomycin (all obtained
fromGibco, Life Technologies, Grand Island, NY) at 37C in a
humidiﬁed 95% air/5% CO2 atmosphere. Culture medium was
replaced every 48 hours. Under these conditions, ureters began
to show spontaneous peristalsis after 3 days in culture. Time-
lapse imaging of ureters was performed after 5 days in culture
using a Leica DM IRE2 inverted microscope (Leica Micro-
systems Inc., Buffalo Grove, IL). Phase-contrast images were
captured every second for 2 minutes and analyzed using Sim-
plePCI imaging software version 5.3.1.081004 (Hamamatsu
Corporation, Sewickley, PA).
Microarray Analysis
Ureters were dissected from two WT and miR-143/145 KO
malemice at 2.5 to 4.5months of age and immediately placed in
RNAlater (Qiagen,Valencia, CA). RNAwas prepared using the
RNeasy Mini kit (Qiagen) according to the manufacturer’s in-
structions. RNAwas tested for purity using the 260 nm/280 nm
and 260 nm/230 nmabsorbance ratios, and for integrity using an
Agilent Bioanalyzer (Agilent Technologies, Santa Clara, CA).
Microarray gene expression analysis was performed by the
University of Virginia Core Lab Microarray Facility using the
Affymetrix mouse gene array ST1.0 (Affymetrix, Santa Clara,
CA). All preprocessing and analysis were performed using R
version 2.15.0. Affymetrix CEL ﬁles were imported using theFigure 3 Histologic analysis of ureters from miR-143/145edeﬁcient mice. He
ureter sections from WT and miR-143/145 KO mice. Histologic analysis shows fre
layer in KO mice. All cell layers are present in the KO ureters. D: Quantitation of
Masson’s trichromeestained sections from each mouse. Examples of where measu
n Z 4; KO, n Z 3. Scale bars: 100 mm.
The American Journal of Pathology - ajp.amjpathol.orgAffymetrix package version 1.34.0. Expression intensities were
summarized, normalized, and transformed using the robust
multiarray average algorithm.19 Probe sets were annotated
using the Bioconductor annotation packages mogene10sttran-
scriptcluster.db version 8.0.1, annotated version 1.34.0 (Bio-
conductor, Fred Hutchinson Cancer Research Center, Seattle,
WA). Probe sets that did not map to an NCBI Entrez Gene
Database were excluded. The dimension reduction and visual-
ization technique of PrincipalComponentsAnalysiswas used to
project the multivariate data vector of each array into a two-
dimensional plot to reﬂect the overall data (dis)similarity be-
tween the arrays and to conﬁrm clustering between samples of
each genotype. The overall sample similarity was conﬁrmed
further by taking the500most differentially expressedgenes and
performing both hierarchical clustering and a heatmap repre-
sentation. For differential gene expression analysis, linear
models with empiric Bayes moderated standard errors were ﬁt
using theBioconductor limmapackage version3.12.1. The false
discovery rate (FDR) was used to correct for multiple testing.20
Data can be accessed at the Gene Expression Omnibus (http://
www.ncbi.nlm.nih.gov/geo; accession number GSE58274).
To determine pathways that could be altered in the miR-
143/145 KO ureters we performed signaling pathway impact
analysis (SPIA), which takes into account the directionality
as well as the topology of the gene networks.21 For this
analysis the 500 most differentially expressed genes were
considered. Data were subjected to both Bonferroni and FDR
corrections.matoxylin and eosin (A), Masson’s trichrome (B), and a-SMA (C) staining of
quent dilatation of the proximal ureter and thinning of the smooth muscle
ureter smooth muscle layer thickness. Quantitation was performed in three
rements were performed are indicated by yellow bars (B). *P < 0.05. WT,
3229
Figure 4 Ureters of miR-143/145edeﬁcient mice show abnormal
contractility. Exposed ureters (arrowheads) of anesthetized 3-month-old
WT and miR-143/145 KO female mice. Quantiﬁcation of peristaltic activity.
The number of ureteral contractions in a 3-minute period was signiﬁcantly
higher in miR-143/145 KO compared with WT mice. Peristalsis in WT mice
occurred in normal, wave-like fashion from the proximal (renal) ureter
toward the bladder, whereas in KO mice it was characterized by frequent,
incomplete contractions that failed to propagate in a proximal-distal di-
rection. ***P < 0.001. k, kidney; u, ureter.
Table 2 Occurrence of Hydronephrosis in WT and miR-143/145
KO Mice
Sex WT miR-143/145 KO
Female 0/8 6/6
Male 0/9 10/10
Total 0/17 16/16
Age of mice ranged from 2 to 8 months.
Medrano et alRNA Extraction and qPCR
Total RNA was extracted as described in the Microarray
Analysis section. cDNA was prepared from 3 mg of RNA
using M-MLV Reverse Transcriptase and an oligo(dT)15
primer mix (both from Promega, Madison, WI). Real-time
quantitative PCR (qPCR) was performed in a CFX Con-
nect system (Bio-Rad, Hercules, CA) using SYBR Green I
(Life Technologies) and Taq DNA polymerase (Promega).
Primer sequences are listed in Table 1. PCR conditions were
run at 95C, 58C, and 72C for 40 cycles.
Statistics
Results are expressed as means  SEM. Signiﬁcance in the
difference of mean values was determined by the Student’s
t-test.
Results
miR-145-5p Is Expressed in the Smooth Muscle Layer
of the Ureter
The miR-143/145 cluster has been studied extensively in the
smooth muscle of the vasculature,15,16 however, its expression
in the ureter has not been reported. To this end,we performed in
situ hybridization in ureter sections of WT mice using3230digoxigenin-labeled oligonucleotide locked nucleic acid
probes. We found that miR-145-5p was expressed exclusively
in the SMC layer of the ureter and the pelvicalyceal system
(Figure 1). The speciﬁcity of the staining was shown by the
absence of signal in ureters of miR-143/145edeﬁcient mice
(Figure 1A), or when the probe was omitted from the hybrid-
ization mix (not shown).
miR-143/145eDeﬁcient Mice Develop Hydronephrosis
To determinewhether themiR-143/145 cluster plays a role in
maintaining the structure and function of the urinary tract, we
conducted morphologic and functional studies in kidneys
and ureters of miR-143/145edeﬁcient mice. We found that
mutant mice developed hydronephrosis characterized by
marked dilatation of the pelvis and calyces accompanied by
severe atrophy of the papilla (Figure 2). Histologic analysis
by hematoxylin and eosin staining did not showmorphologic
changes at the level of the renal cortex in mice lacking miR-
143/145. The structure of glomeruli, blood vessels, and
proximal and distal tubules appeared normal in the mutant
mice (Figure 2B). Interestingly, immunostaining experi-
ments showed normal expression of the smooth muscle
marker a-SMA in JG cells and renal arterioles of miR-143/
145 KO mice (Supplemental Figure S1). This was an unex-
pected result owing to the important role of miR-143/145 in
vascular smooth muscle development15 and the high
expression of miR145-5p in JG cells and in the kidney
vasculature.17 Immunostaining for renin showed that JG
cells in miR-143/145 KO mice are plump compared with
controls. This difference is consistent with the low blood
pressure in miR-143/145 KO mice.
Next, we sought to examine the morphology of ureters
from miR-143/145 KO mice. Histologic analysis of ureter
sections by hematoxylin and eosin and Masson’s trichrome
staining as well as immunostaining for a-SMA conﬁrmed
that all cell layers were present in mutant mice (Figure 3,
AeC). However, frequent distension of the proximal ureter
(Figures 3, A and B, and 4) and a signiﬁcant thinning of the
smooth muscle layer was evident in miR-143/145 KO mice
(Figure 3). Interestingly, reduced thickness of the smooth
muscle layer also has been observed in the aorta of miR-
143/145 KO mice.16 By direct anatomic examination, we
did not ﬁnd evidence of an abnormal connection between
the kidney and the ureter or a physical obstruction of the
ureter (not shown), suggesting that hydronephrosis may be
caused by a functional obstruction of the urinary system.ajp.amjpathol.org - The American Journal of Pathology
Figure 5 Gene expression proﬁling in ureters from WT and miR-143/145 KO mice. Total RNA samples from WT and mutant ureters were analyzed using Affymetrix
GeneChip Mouse Gene 1.0 ST arrays. A: Volcano plot shows the fold-difference in the expression and the signiﬁcance of the difference for all genes in the arrays. B:
Heatmap shows differentially expressed genes in ureters frommiR-143/145 KOmice. Of the 108 differentially expressed genes, 90 were up-regulated and 18 were down-
regulated. Each column represents results from an independent animal (indicated as WT1, WT2, KO1, and KO2). Each row corresponds to a single gene probe. The color
indicates the level of mRNA expression (red, high expression; green, low expression). We used hierarchical cluster analysis of gene expression to group genes with similar
expression patterns as indicated at the left side of the map. C: SPIA of genes showing differential expression in miR-143/145 KO ureters. A two-dimensional plot shows
the relationship between the gene over-representation (x axis) and the perturbation of the pathways (y axis) analyzed by SPIA.We considered the 500most differentially
expressed genes for the analysis. Each point represents a pathway. The x axis shows the P value on the over-representation of differentially expressed genes in the given
pathway: P(NDE). The y axis shows the signiﬁcance of the overall perturbation of the pathway: P(PERT). Pathways above the red line are signiﬁcant at 5% after
Bonferroni correction, and pathways above the blue line are signiﬁcant at 5% after FDR correction. The vertical and horizontal thresholds represent the same corrections
for the two types of evidence considered individually. Indicated in green are relevant pathways that did not meet both the over-representation and perturbation criteria
but were above a 10% cut-off of the FDR-corrected overall P value: P(G)FDR. For pathways 4512 and 5414, the actuallog P(NDE) values were 22 and 14.5, respectively.
These values were cut off from the plot as indicated by the black vertical line on the left side of the point. Numbers are the Kyoto Encyclopedia of Genes and Genomes
(Kegg) database identiﬁcation number for the pathway: 4512, ECM-receptor interaction; 5414, dilated cardiomyopathy; 4510, focal adhesion; 5412, arrhythmogenic
right ventricular cardiomyopathy; 4350, transforming growth factor-b signaling pathway; 4270, vascular smooth muscle contraction; 4340, hedgehog signaling
pathway; 4810, regulation of actin cytoskeleton; 4020, calcium signaling pathway; 5146, amebiasis; 5144, malaria; and 5202, transcriptional dysregulation in cancer.
Genes related to smooth muscle biology are marked with asterisks. FC, fold-change; NS, not signiﬁcant (P > 0.05); S, signiﬁcant (P < 0.05).
miR-143/145 and Hydronephrosis
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Table 3 Dysregulated Pathways in miR-143/145eDeﬁcient Ureters
Pathway name pGFdr Status Kegg pathway ID
Pathways related to smooth muscle biology
ECM-receptor interaction 3.99  1008 Activated 4512
Dilated cardiomyopathy 6.34  1006 Inhibited 5414
Focal adhesion 0.0003 Activated 4510
Arrhythmogenic right ventricular cardiomyopathy 0.0014 Inhibited 5412
TGF-b signaling pathway 0.0023 Activated 4350
Vascular smooth muscle contraction 0.0432 Activated 4270
Hedgehog signaling pathway 0.0440 Inhibited 4340
Regulation of actin cytoskeleton 0.0728 Activated 4810
Calcium signaling pathway 0.0746 Inhibited 4020
Other pathways
Malaria 0.0076 Inhibited 5144
Amebiasis 0.020 Activated 5146
Transcriptional dysregulation in cancer 0.022 Inhibited 5202
Microarray data were subjected to SPIA using the 500 most differentially expressed genes. Data above a 10% cut-off of the FDR-corrected overall P-value
pGFdr are shown.
ECM, extracellular matrix; Kegg, Kyoto Encyclopedia of Genes and Genomes database; TGF, transforming growth factor.
Medrano et alWe found that hydronephrosis occurred in both male and
female mutant mice as early as 2 months of age (Table 2). In
addition, hydronephrosis developed gradually during post-
natal life in miR-143/145edeﬁcient mice. We observed that
kidneys from younger animals (ie, 2 weeks of age) had no
major abnormalities (not shown), suggesting a progressive
effect of miR-143/145 deﬁciency on the kidney.
To determine whether miR-143/145 deﬁciency leads to
impaired renal function, we measured blood urea nitrogen
and plasma creatinine levels of mutant mice.22 Both urea
nitrogen and creatinine levels were slightly, but not signif-
icantly, increased in mutant mice compared with WT lit-
termates up to 8 months of age (Supplemental Figure S2).
These results are consistent with the overall normal
appearance of the kidney cortex and the absence of any sign
of early health decline or reduced life span of miR-143/
145edeﬁcient mice.
Ureters of miR-143/145eDeﬁcient Mice Show
Abnormal Contractility
Given the apparent lack of physical obstruction in mice
deﬁcient for miR-143/145 we sought to determine whether
abnormal ureteric peristalsis contributes to the hydro-
nephrosis phenotype. The number of peristaltic waves
recorded in exposed ureters of anesthetized animals was
signiﬁcantly higher in miR-143/145 KO mice compared
with WT controls (Figure 4 and Supplemental Videos S1
and S2). Moreover, peristaltic waves were short, more
frequent, and failed to completely propagate in a proximal-
distal direction (Supplemental Videos S1 and S2). We next
sought to analyze peristaltic activity in isolated ureters using
an in vitro culture system of embryonic ureters.23 Embry-
onic day 16.5 ureter explants from WT mice grown for 5
days on membranes in the air-medium interface acquired the
ability to generate peristaltic waves that propagated in a3232proximal-distal direction. Ureters from miR-143/145e
deﬁcient embryos also developed peristalsis in culture and
showed a slight, but not signiﬁcant, increase in the number
of contractions measured over a period of 2 minutes
(Supplemental Figure S3). These results indicate that
abnormal peristalsis progresses gradually and becomes
evident later in postnatal life.
Taken together, these data indicate that hydronephrosis in
miR-143/145edeﬁcient mice likely is the result of the
abnormal peristaltic activity of the ureter and that this path-
ologic condition progresses gradually with age.
Ureters from miR-143/145eDeﬁcient Mice Have an
Altered Pattern of Gene Expression
To gain insight into the mechanism of impaired peristalsis
leading to hydronephrosis we sought to identify genes with
altered expression in miR-143/145edeﬁcient ureters. Ac-
cording to miRWalk and other databases (http://www.umm.
uni-heidelberg.de/apps/zmf/mirwalk, last accessed May 5,
2014), miR-143 and miR-145 have the potential to targeting
more than 1000 genes by binding to putative binding sites in
the 30 untranslated region of these genes.We conducted a gene
expression proﬁling analysis on total RNA isolated from
ureters of WT and miR-143/145 KO mice. Figure 5 provides
an overview of the gene expression pattern of WT and mutant
ureters. We found that 108 genes were expressed differentially
(using an adjusted PFDR < 0.05 as the threshold for signiﬁ-
cance). Ninety genes were up-regulated and 18 genes were
down-regulated in the miR-143/145 KO ureters. The fact that
most genes (83%) were up-regulated is consistent with the
well-established negative effect of miRNAs on gene expres-
sion. Figure 5A shows the results as a volcano plot, which
illustrates the fold-difference in the expression, and the sig-
niﬁcance of the difference, for all genes in the arrays. We
conducted a hierarchical cluster analysis of genes whichajp.amjpathol.org - The American Journal of Pathology
miR-143/145 and Hydronephrosisshowed signiﬁcant differential expression (PFDR < 0.05) with
the purpose of grouping genes with similar expression patterns
(Figure 5B). This analysis showed a few signiﬁcantly dysre-
gulated genes involved in smooth muscle development and/or
function (eg, myocardin,24,25 stanniocalcin-1,26 hedgehog-
interacting protein,27 tenascin C,28 arginine vasopressin re-
ceptor 1A,29 thrombospondin 2,30 and a11 integrin31).
SPIA Shows Several Signiﬁcantly Perturbed Pathways
in the Ureters of miR-143/145 KO Mice
Considering that miRNAs often regulate biological pro-
cesses by their modest effects on numerous targets,32,33 we
sought to identify biological pathways that may be altered
in the miR-143/145 KO ureters by performing SPIA21 on
the annotated Kyoto Encyclopedia of Genes and Genomes
pathway database. To identify perturbed networks of genes
and pathways, SPIA takes into consideration the over-
representation and the function of dysregulated genes in
a given pathway as well as the extent of gene expression
changes. By taking into account both the directionality and
the topology of the gene networks, SPIA can detect per-
turbed pathways even in situations in which the number of
genes or the change in expression of the genes in a given
pathway is relatively low. The SPIA analysis output of our
gene array data is shown in Figure 5C. We found 12
signiﬁcantly perturbed and enriched pathways (Table 3).
Interestingly, nine of these pathways corresponded to
biological processes that involved genes that were associ-
ated directly or indirectly to smooth muscle biology
(Table 3). Table 4 shows the genes represented in each
perturbed pathway. We found that almost half of the 108
dysregulated genes (46 genes: 40 up-regulated and 6
down-regulated) accounted for these perturbed pathways.
Altered Expression of Selected Genes in Ureters from
miR143/145 KO Mice as Assessed by qPCR
To corroborate the microarray and SPIA results, we mea-
sured the expression of selected mRNAs by qPCR. We
focused on genes involved directly in smooth muscle
contraction because of the abnormal ureter peristaltic ac-
tivity of miR-143/145 KO mice, and on genes involved in
ECM-receptor interaction because this pathway is important
for smooth muscle function34 and is the most dysregulated
pathway in our analysis with a FDR-corrected overall
P value (pGFdr) of 3.99  1008. We found that the
expression levels of all selected genes were higher in ureters
from miR-143/145 KO mice compared with their WT
counterparts (Figure 6). In the cases of Cacna1d, Kcnma1,
and Itga3, the differences in expression were not signiﬁcant,
which was expected as a result of the modest effect of these
miRNAs shown by our microarray analysis. We also
measured the levels of Myocd and its target a-SMA (Acta2)
in ureters of WT and miR-143/145 KO mice by qPCR. The
results showed a slight but nonsigniﬁcant increase inThe American Journal of Pathology - ajp.amjpathol.orgmyocardin in miR-143/145 KO mice. The levels of a-SMA
were not different between the two groups. In agreement
with these ﬁndings, normal levels of myocardin and a-SMA
also were reported in SMCs of aorta from miR-143/145
KO mice.16
Overall, these results corroborate the microarray and the
in silico data and support the concept that miR-143/145
deﬁciency results in a pattern of gene dysregulation in
pathways that are important for normal ureteric peristalsis.Discussion
Here, we show that miR-143/145, a miRNA cluster that
regulates the phenotype and fate of smooth muscle cells in
vascular tissue,15,16 is crucial for the normal function of the
urinary tract. We found that mice lacking whole-body
expression of miR-143/145 show compromised ureter
peristaltic activity, which results in hydronephrosis as early
as 2 months postnatally.
The phenotype of miR-143/145edeﬁcient mice is char-
acterized by severe papillary atrophy and marked dilatation
of the pelvicalyceal system and ureter. These major
phenotypic abnormalities indicate that these two miRNAs
are indispensable for the maintenance of the structure and
function of the urinary tract. Despite the high expression of
miR-145-5p in the JG cells and vasculature of the kidney,17
we did not ﬁnd any evident alteration in the structure of
either renal vessels or the JG area by light microscopy
examination. The structure of the tubules and glomeruli
also appeared normal in miR143/145 KO mice. Most
importantly, we did not ﬁnd changes in the pattern of
a-SMA staining in the blood vessels. Immunostaining for
renin showed that JG cells in KO mice are plump compared
with controls, suggesting increased renin production. It is
likely that this increase is in response to the low blood
pressure that results from the reduced vascular tone shown
in miR143/145 KOmice.16 Alternatively, the existence of a
putative miR-145-5p binding site in the 30 untranslated
region of renin, as predicted by miRWalk and other data-
bases, suggests the possibility of a direct effect of miR-145-
5p on renin expression. Ultrastructural studies16,35 on large
arteries of miR-143/145edeﬁcient mice (eg, the aorta and
femoral artery) have shown thinning of the smooth muscle
layer of the vessels, a reduced number of actin-based stress
ﬁbers, and a switch to a synthetic smooth muscle pheno-
type. Therefore, additional studies at the electron micro-
scope level are necessary to determine whether the kidney
vasculature is affected similarly.
Given that we did not ﬁnd any indication of a physical
obstruction of the urinary tract associated with the hydro-
nephrosis phenotype, we hypothesized that the lack of miR-
143/145 was the result of a functional obstruction caused by
abnormal ureter smooth muscle contraction and resulting in
impaired peristalsis. We conﬁrmed this hypothesis by
observing that miR-143/145 KO mice showed an abnormal3233
Table 4 Dysregulated Genes in Altered Pathways
Gene
symbol Gene name FC
ECM-
receptor
interaction
Dilated
cardio-
myopathy
Focal
adhesion ARVC
TGF-b
signaling
pathway
Vascular
smooth
muscle
contraction
Hedgehog
signaling
pathway
Regulation
of actin
cytoskeleton
Calcium
signaling
pathway
Cacna1d Calcium channel,
L-type a1D subunit
1.6    
Prkch Protein kinase C, h 1.9 
Adra1d Adrenergic receptor
a1d
0.6  
Ppp1r14a Protein phosphatase
1, regulatory
subunit 14A
1.7 
Kcnma1 Potassium large-
conductance
calcium-activated,
M, a member 1
1.9 
Pla2g4a Phospholipase A2,
group IVA
2.0 
Adora2b Adenosine A2b
receptor
1.8  
Avpr1a Arginine vasopressin
receptor 1A
3.5  
Ramp1 Receptor G-proteine
coupled, activity-
modifying protein 1
1.8 
Itga3 Integrin a3 1.7     
Itga4 Integrin a4 1.6     
Itga8 Integrin a8 1.8     
Itga11 Integrin a11 2.5     
Itgb6 Integrin b6 1.9     
Lama2 Laminin, a2 1.8    
Lama5 Laminin, a5 1.7  
Lamb3 Laminin, b3 1.8  
Col6a3 Collagen, type VI, a3 1.5  
Col1a1 Collagen, type I, a1 1.9  
Col1a2 Collagen, type I, a2 1.7  
Tnc Tenascin C 3.5  
Thbs1 Thrombospondin 1 1.9   
Thbs2 Thrombospondin 2 2.9   
Npnt Nephronectin 1.9 
BclII B-cell leukemia/
lymphoma 2
1.6 
Pdgfd Platelet-derived
growth factor D
2.2  
Cdh2 Cadherin 2 0.5 
Sgcg Sarcoglycan, g 0.4  
Dmd Dystrophin 2.0  
Tgfb2 Transforming growth
factor, b2
1.7  
Tgfb3 Transforming growth
factor, b3
2.0  
Bmp2 Bone morphogenetic
protein 2
2.0  
Bmp4 Bone morphogenetic
protein 4
2.2  
Bmp5 Bone morphogenetic
protein 5
3.5  
Ptch1 Patched homolog 1 1.6 
(table continues)
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Table 4 (continued )
Gene
symbol Gene name FC
ECM-
receptor
interaction
Dilated
cardio-
myopathy
Focal
adhesion ARVC
TGF-b
signaling
pathway
Vascular
smooth
muscle
contraction
Hedgehog
signaling
pathway
Regulation
of actin
cytoskeleton
Calcium
signaling
pathway
Wnt5a Wingless-related
MMTV integration
site family,
member 5A
1.7 
Hhip Hedgehog
interacting protein
3.1 
Fgf7 Fibroblast growth
factor 7
1.8 
Myh10 Myosin, heavy
polypeptide 10,
nonmuscle
1.7 
Itpka Inositol-
trisphosphate
3-kinase A
0.5 
Slc8a3 Solute carrier family
8 (sodium/calcium
exchanger),
member 3
1.9 
Ppp3ca Protein phosphatase
3, catalytic
subunit, a isozyme
1.6 
Igh/Igh-
VJ558
Immunoglobulin
heavy chain (J558
family)
0.3  
Gna15 Guanine nucleotide
binding protein (G
protein), a15 (Gq
class)
1.9 
Ptger1 Prostaglandin E
receptor 1
(subtype EP1)
1.6 
Ptger3 Prostaglandin E
receptor 3
(subtype EP3)
0.5 
ARVC, arrhythmogenic right ventricular cardiomyopathy; ECM, extracellular matrix; FC, fold-change; Kegg, Kyoto Encyclopedia of Genes and Genomes
database; TGF, transforming growth factor.
miR-143/145 and Hydronephrosispattern of peristaltic waves characterized by frequent and
incomplete ureteral contractions. The fact that peristalsis
was not altered in embryonic ureter explants (ie, mutant
ureters showed peristaltic waves similar to those of WT
embryos) indicates that the effect of miR-143/145 deﬁ-
ciency progresses gradually with age. Therefore, it is
possible that in the absence of miR-143/145 the smooth
muscle of the ureter does not contract efﬁciently, resulting
in a gradual accumulation of ﬂuid in the kidney with age.
Our ﬁnding of several dysregulated genes and pathways
related to smooth muscle supports this idea. On the other
hand, it can be argued that the effect may not be entirely
intrinsic to the ureter and therefore is not evident in the
detached organ (ie, embryo explants). Although myogenic
mechanisms are key regulators of ureteral peristalsis,
neurogenic factors also play an important role in thisThe American Journal of Pathology - ajp.amjpathol.orgprocess.36 Therefore, it is possible that neurogenic factors
contribute to the miR-143/145 KO phenotype. For example,
SPIA analysis showed inhibition of the cholinergic synapse
pathway [FDR-corrected overall P value (pGFdr)Z 0.105]
in the miR-143/145 KO ureters. Further studies involving
pharmacologic manipulations of isolated ureters are
necessary to elucidate the mechanism of altered peristalsis
in miR-143/145edeﬁcient mice.
Although some of the genes and pathways that control
normal ureteric function are known,36 the involvement of
speciﬁc miRNAs has not been reported previously. It is
well accepted that normal smooth muscle contraction re-
quires a ﬁne control of expression of many genes. Given
that miRNAs in general, and miR-143/145 in particular,
have the potential to inﬂuence the activity of thousands of
genes, it is likely that the impaired peristalsis shown by3235
Medrano et almiR-143/145edeﬁcient mice could be the result of the
dysregulation of several genes that control and maintain
ureteric function. Although we found a signiﬁcant number
of up-regulated genes, which is consistent with the well-Figure 6 mRNA levels of genes related to smoothmuscle biology in ureters
frommiR-143/145 mice. Expression levels of selected genes were measured by
qPCR. The selection of genes was based on SPIA results. Expression levels of
genes involved in vascular smooth muscle contraction (A), ECM-receptor
interaction (B), and smooth muscle transcriptional regulator myocardin and
its target a-SMA (C). Values are means  SEM of four animals. Statistical
analysis was performed using the Student’s t-test. Inmost cases the differences
between WT and miR-143/145 KOmice were signiﬁcant. For Cacna1d, Kcnma1,
Itga3, and Myocd the differences were not signiﬁcant but levels were slightly
higher in the mutant ureters, in agreement with the microarray results. Levels
ofa-SMAwere not changed. Primer sequences and qPCR conditions are listed in
Table 1. The expression of glyceraldehyde-3-phosphate dehydrogenase was
used as an internal control. *P < 0.05, **P < 0.01 versus WT.
3236known inhibitory effect of miRNAs in gene expression,
only a few dysregulated genes were related to smooth
muscle structure and function. We reasoned that because
individual miRNAs can act on entire gene networks instead
of on single genes alone, even moderate or minimal
changes in expression of these genes could have a great
effect on a given pathway or biological process. In agree-
ment with our prediction, the results of the SPIA analysis
determined several pathways that were altered in the miR-
143/145 KO ureters. More importantly, some of these
pathways and biological processes are associated with
smooth muscle biology. Therefore, we were able to iden-
tify affected genes that otherwise would not have been
chosen for further investigation owing to modest changes
in their expression. These results stress the importance
of using pathway analysis when performing miRNA
KO studies.
There likely are multiple mechanisms underlying the
changes we found in the kidneys and ureters of mutant mice. It
is important to recognize that it is unlikely that the dysregu-
lation of a single gene can account solely for the observed
phenotype. To our knowledge, there are no studies of over-
expression of the genes that we found up-regulated in our ar-
rays that resulted in a similar phenotype as the one described in
this study. miRNAs generally act as negative post-transcrip-
tional regulators of mRNAs, therefore suppressing the
expression of miRNAs should produce changes that are
opposite to those of their predicted target mRNAs. We found
that up-regulated genes are related not only to smooth muscle
contraction, but also to ECM-receptor interaction. Surface
adhesion receptors and their ligands are known regulators of
SMC functions, including contraction.34 Interestingly, altered
expression of integrins and other ECM proteins has been re-
ported in patients with ureteropelvic junction obstruction.37
Further studies aimed at establishing the role of the ECM-
receptor pathway in the smooth muscle cells of the ureter in
miR-143/145 KO mice may help to elucidate the pathogenic
mechanism underlying the phenotype described here.
The ﬁndings reported here are consistent with a model
in which miR-143/145 ﬁne-tune the expression of mul-
tiple genes related to smooth muscle contraction and
that deﬁciency of these miRNAs results in a chronic
impairment in peristalsis and a gradual development of
hydronephrosis. This phenotype closely resembles ﬁnd-
ings encountered in patients with nonobstructive (func-
tional) hydronephrosis. Currently, there are no predictive
indicators of nonobstructive hydronephrosis in humans.
Down-regulation of miR-145 recently was documented
in patients affected by chronic kidney disease38 and
renal cell carcinoma.39,40 At present, there are no reports
on miR-143/145 expression in patients affected by
hydronephrosis. Our ﬁndings suggest that the miR-143/
145 cluster should be considered a potential underly-
ing factor in the development of nonobstructive hydro-
nephrosis in humans. Future work needs to be
performed to determine whether miR-143/145 offer anajp.amjpathol.org - The American Journal of Pathology
miR-143/145 and Hydronephrosisopportunity for the diagnosis and management of func-
tional hydronephrosis.
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